216 related articles for article (PubMed ID: 17962192)
81. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
Lutz LM; Pace CR; Arnold MM
J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
[TBL] [Abstract][Full Text] [Related]
82. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
83. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.
Ravet E; Reynaud D; Titeux M; Izac B; Fichelson S; Roméo PH; Dubart-Kupperschmitt A; Pflumio F
Blood; 2004 May; 103(9):3326-35. PubMed ID: 14715640
[TBL] [Abstract][Full Text] [Related]
84. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
85. Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.
Spensberger D; Kotsopoulou E; Ferreira R; Broccardo C; Scott LM; Fourouclas N; Ottersbach K; Green AR; Göttgens B
Exp Hematol; 2012 Jul; 40(7):588-598.e1. PubMed ID: 22401818
[TBL] [Abstract][Full Text] [Related]
86. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.
Hu X; Li X; Valverde K; Fu X; Noguchi C; Qiu Y; Huang S
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10141-6. PubMed ID: 19497860
[TBL] [Abstract][Full Text] [Related]
87. The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr.
Castiel A; Danieli MM; David A; Moshkovitz S; Aplan PD; Kirsch IR; Brandeis M; Krämer A; Izraeli S
J Cell Sci; 2011 Feb; 124(Pt 4):532-9. PubMed ID: 21245198
[TBL] [Abstract][Full Text] [Related]
88. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
Chandra Dantu S; Nathubhai Kachariya N; Kumar A
Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
[TBL] [Abstract][Full Text] [Related]
89. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
90. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
[TBL] [Abstract][Full Text] [Related]
91. The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication.
Ali A; Farooqui SR; Banerjea AC
J Biol Chem; 2019 May; 294(18):7283-7295. PubMed ID: 30885946
[TBL] [Abstract][Full Text] [Related]
92. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Appleman LJ; Chernova I; Li L; Boussiotis VA
Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
[TBL] [Abstract][Full Text] [Related]
93. Nik-related kinase is targeted for proteasomal degradation by the chaperone-dependent ubiquitin ligase CHIP.
Naito S; Fukushima T; Endo A; Denda K; Komada M
FEBS Lett; 2020 Jun; 594(11):1778-1786. PubMed ID: 32162334
[TBL] [Abstract][Full Text] [Related]
94. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.
Xia T; Dimitropoulou C; Zeng J; Antonova GN; Snead C; Venema RC; Fulton D; Qian S; Patterson C; Papapetropoulos A; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3080-7. PubMed ID: 17873020
[TBL] [Abstract][Full Text] [Related]
95. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
96. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
Hochman E; Kinston S; Harmelin A; Göttgens B; Izraeli S
Exp Hematol; 2006 Dec; 34(12):1643-50. PubMed ID: 17157160
[TBL] [Abstract][Full Text] [Related]
97. UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells.
Sane S; Hafner A; Srinivasan R; Masood D; Slunecka JL; Noldner CJ; Hanson AD; Kruisselbrink T; Wang X; Wang Y; Yin J; Rezvani K
Mol Oncol; 2018 Oct; 12(10):1753-1777. PubMed ID: 30107089
[TBL] [Abstract][Full Text] [Related]
98. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators.
Tijssen MR; Cvejic A; Joshi A; Hannah RL; Ferreira R; Forrai A; Bellissimo DC; Oram SH; Smethurst PA; Wilson NK; Wang X; Ottersbach K; Stemple DL; Green AR; Ouwehand WH; Göttgens B
Dev Cell; 2011 May; 20(5):597-609. PubMed ID: 21571218
[TBL] [Abstract][Full Text] [Related]
99. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
[TBL] [Abstract][Full Text] [Related]
100. Identification of the degradation determinants of insulin receptor substrate 1 for signaling cullin-RING E3 ubiquitin ligase 7-mediated ubiquitination.
Xu X; Keshwani M; Meyer K; Sarikas A; Taylor S; Pan ZQ
J Biol Chem; 2012 Nov; 287(48):40758-66. PubMed ID: 23045529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]